To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.

HR 1843 (119th Congress) is federal legislation introduced in the U.S. House of Representatives on March 5, 2025. Sponsored by Rep. Dunn, Neal P. [R-FL-2]. Current status: Referred to the House Committee on Energy and Commerce. (2025-03-05).